sftd

GeneSearchâ„¢ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved

Filed in archive Diagnostics , News on July 17, 2007

GeneSearch_BLN_assay_kit.jpg
The US FDA has just approved the first molecular-based laboratory test for detecting metastasized breast cancer: GeneSearchâ„¢ Breast Lymph Node (BLN) Assay.

Manufactured by Veridex (a Johnson & Johnson Company), GeneSearchâ„¢ BLN Assay detects molecules that are abundant in breast tissue but scarce in a normal lymph node.

The presence or absence of breast cancer cells in underarm lymph nodes is a powerful predictor of whether the cancer has spread and is used to help decide appropriate therapy for a woman with metastatic breast cancer.

Lymph nodes are part of the system that helps protect the body against infection. The first lymph node that filters fluid from the breast is called the "sentinel node," because that is where breast cancer cells are likely to spread first.


Find more details from the full report.



Permalink: GeneSearchâ„¢ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved

Tags: GeneSearchâ„¢  Breast  Lymph  Node  BLN  Assay  metastatic  breast  cancer  contact  breast+cancer 

Vote for GeneSearchâ„¢ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved:

  • Currently 7.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.00 out of 3 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Allergies   Alzheimer's Disease   Arthritis   Bacteria and Bacterial Infections   Best of   Blog Carnivals   Bone Health   Cancer   Cardiovascular Health   Cases   CFS   Consumer Alert   Controversies   Dental Health   Diabetes   Diagnostics   Diarrhea   Did you know   Diet   Dietary Supplements and Vitamins